Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • LRRK2 Therapeutic and Safety Initiative, 2017
    Using Organs-on-Chips to Test the Safety of New Drugs for Parkinson's Disease

    Study Rationale:
    Organs-on-Chips is a technology that recreates human biology in a microscopic device. In simple terms, the device comprises cells from a human organ, such as the lungs, attached to a...

  • LRRK2 Therapeutic and Safety Initiative, 2017
    Genetic and Clinical Basis for Inflammatory Bowel Disease and Parkinson's Disease Comorbidity

    Study Rationale:
    Recent studies have shown that mutations in the LRRK2 gene, known to increase the risk of Parkinson’s disease (PD), are also associated with inflammatory bowel disease (IBD), a...

  • LRRK2 Biology Consortium, 2017
    LRRK2 Activity and Dyskinesia

    Promising Outcomes of Original Grant:
    Leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD). We previously studied the role of LRRK2 in the...

  • Computational Science, 2017
    International Study of Parkinson's-related Changes in Brain Pathways Using Imaging Technique

    Study Rationale:
    Because Parkinson's disease (PD) affects people around the world regardless of their ethnicity or place of residence, research to find a cure for Parkinson's is truly an international...

  • Research Grant, 2017
    T Cell-mediated Autoimmune Responses in Parkinson's Disease

    Study Rationale
    The protein alpha-synuclein, which is misprocessed in nearly every case of Parkinson's disease (PD), forms the Lewy bodies seen in PD patient brain. In our recent MJFF-funded study, our...

  • Research Grant, 2017
    Using Immune Cells to Treat Parkinson's Disease

    Study Rationale:
    While significant strides have been made toward therapies that can prevent, slow or stop Parkinson's disease (PD) progression, no currently approved Parkinson's treatment can do this...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.